News
Important Only
Zyus Life Sciences Reports Preliminary Results From Ongoing Phase 2A Utopia-1 Trial
Jan 8 (Reuters) - ZYUS Life Sciences Corp ZYUS.V:ZYUS LIFE SCIENCES REPORTS PRELIMINARY RESULTS FROM ONGOING PHASE 2A UTOPIA-1 TRIAL EVALUATING NOVEL NON-OPIOID PAIN DRUGZYUS LIFE SCIENCES CORP - EARLY DATA FROM PHASE 2A UTOPIA-1 TRIAL SUGGESTS IMPROVEMENT IN PAIN EFFICACYZYUS LIFE SCIENCES CORP - T...Reuters
Thu, Jan 8
Clearway Energy Operating Llc Announces Proposed Offering Of $500 Million Of Senior Notes
Jan 8 (Reuters) - Clearway Energy Inc CWENa.N:CLEARWAY ENERGY OPERATING LLC, A SUBSIDIARY OF CLEARWAY ENERGY, INC., ANNOUNCES PROPOSED OFFERING OF $500 MILLION OF SENIOR NOTESFurther company coverage: [CWENa.N]Reuters
Thu, Jan 8
Greenpower Motor Company Chooses New Mexico For Advanced Ev Manufacturing Facility
Jan 8 (Reuters) - GreenPower Motor Company Inc GP.O:GREENPOWER MOTOR COMPANY CHOOSES NEW MEXICO FOR ADVANCED EV MANUFACTURING FACILITYGREENPOWER MOTOR: MOVE IS ESTIMATED TO GENERATE OVER $200 MILLION IN ECONOMIC IMPACT FOR NEW MEXICO OVER THE NEXT DECADE, CREATING MORE THAN 340 JOBSReuters
Thu, Jan 8
Paramount Reaffirms Commitment To Delivering Superior $30 Per Share All-Cash Offer To Warner Bros. Discovery Shareholders
Jan 8 (Reuters) - Paramount Skydance Corp PSKY.O:PARAMOUNT REAFFIRMS COMMITMENT TO DELIVERING SUPERIOR $30 PER SHARE ALL-CASH OFFER TO WARNER BROS. DISCOVERY SHAREHOLDERSPARAMOUNT SKYDANCE CORP: PARAMOUNT'S ANALYSIS VALUES DISCOVERY GLOBAL AT $0.00 PER SHAREReuters
Thu, Jan 8
A2 Biotherapeutics Receive FDA Clearance Of Ind For A2b543
Jan 8 (Reuters) - A2 BIOTHERAPEUTICS: RECEIVE FDA CLEARANCE OF IND FOR A2B543A2 BIOTHERAPEUTICS: FDA CLEARANCE FOR A2B543 FOR TREATMENT OF ADULTS WITH RECURRENT UNRESECTABLE, LOCALLY ADVANCED, OR METASTATIC SOLID TUMORSFurther company coverage: [ ]Reuters
Thu, Jan 8
Sentinelone Achieves Govramp Authorization At The High Impact Level For Its Ai-Powered Singularity Cybersecurity Platform
Jan 8 (Reuters) - SentinelOne Inc S.N:SENTINELONE ACHIEVES GOVRAMP AUTHORIZATION AT THE HIGH IMPACT LEVEL FOR ITS AI-POWERED SINGULARITY CYBERSECURITY PLATFORMSENTINELONE INC - MAINTAINS FEDRAMP HIGH AUTHORIZATION FOR ENDPOINT, PURPLE AI, CNAPP, AND HYPERAUTOMATION SOLUTIONSReuters
Thu, Jan 8
Kevin Guest Returns To Usana Health Sciences As CEO
Jan 8 (Reuters) - USANA Health Sciences Inc USNA.N:KEVIN GUEST RETURNS TO USANA HEALTH SCIENCES AS CEOUSANA HEALTH SCIENCES INC - JIM BROWN STEPS DOWN AS CEO AND PRESIDENT OF USANAUSANA HEALTH SCIENCES INC - KEVIN GUEST TO CONTINUE AS CHAIRMANReuters
Thu, Jan 8
Haveli to buy majority stake in contract software firm Sirion
By Isla Binnie and Milana VinnJan 8 (Reuters) - U.S. private equity firm Haveli Investments has agreed to make a majority investment in Sirion, which provides software that uses artificial intelligence to draft, store and manage business contracts, the companies said on Thursday. WHAT HAS BEEN A...Reuters
Thu, Jan 8
Cormedix Therapeutics Announces Leadership And Board Updates
Jan 8 (Reuters) - CorMedix Inc CRMD.O:CORMEDIX THERAPEUTICS ANNOUNCES LEADERSHIP AND BOARD UPDATESCORMEDIX INC - CEO JOSEPH TODISCO SIGNS EXTENDED EMPLOYMENT CONTRACTCORMEDIX INC - JOSEPH TODISCO ASSUMES ROLE OF CHAIRMAN OF THE BOARDReuters
Thu, Jan 8
